|
Intelligent Medical Implants |
|
|
Niebuhrstrasse 1a
Bonn, D-53113 Germany
phone:+49 (0) 228 - 969 55 0
fax:+49 (0) 228 - 969 55 22
|
|
| Symbol |
Private |
| Founded |
2002 |
| Employees |
30 |
|
|
| www.intmedimplants.de
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| 'Artificial Retina' for Patients with Degenerative Retinal Disorders |
|
| Management |
| Hans-Jurgen Tiedtke, Vice president of Technology; Robert Hill, Vice president of Operations; Andre-Michel Ballester, Director; Vincent Bucci, Director; Timothy J. Haines, Director |
| |
|
|
| |
|
| Keywords |
| immunology, interdisciplinary, neurostimulation, algorithms, optoelectronic |
|
|
|
| Description |
|
Intelligent Medical Implants (IMI) has developed an 'artificial retina' designed to restore natural visual information processing functions in patients suffering from degenerative retinal disorders. The device gathers images from the surroundings using a built-in camera and subsequently translates them into electrical stimulation commands within the eye. Blind patients can then acquire modest visual perception and enhanced sense of orientation. |
|
| Products / Services |
IRIS- Intelligent Retinal Implant System, is a visual prosthesis, artifcial retina, that bridges damged function of the real retina.
|
|
| Technology / Differentiation |
| The Learning Retina Implant System has a modular design and consists of three main components: the Retinal Stimulator (the component actually implanted in the eye), the Visual Interface and the Pocket Processor.The Visual Interface includes a built-in camera that captures images from the wearers surroundings. |
|
| Market / Customers |
The company's retinal implant is currently undergoing clinical trials; it holds a market potential of 8 billion Euros for retinitis pigmentosa and 30 billion Euros for ARMD.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members